about
Neurotoxicity of Alzheimer's disease Aβ peptides is induced by small changes in the Aβ42 to Aβ40 ratioThe Small Subunit rRNA Modification DatabaseSynthetic strategy and antiviral evaluation of diamide containing heterocycles targeting dengue and yellow fever virusA novel, highly selective inhibitor of pestivirus replication that targets the viral RNA-dependent RNA polymerase.Cleavage of DNA without loss of genetic information by incorporation of a disaccharide nucleosideThe RNA Modification Database, RNAMDB: 2011 updateZebrafish bioassay-guided natural product discovery: isolation of angiogenesis inhibitors from East African medicinal plantsThe antimicrobial compound xantholysin defines a new group of Pseudomonas cyclic lipopeptidesDiscovery of an acyclic nucleoside phosphonate that inhibits Mycobacterium tuberculosis ThyX based on the binding mode of a 5-alkynyl substrate analogue.Mass spectrometric fragmentation of cyclic peptides belonging to the polymyxin and colistin antibiotics studied by ion trap and quadrupole/orthogonal-acceleration time-of-flight technology.Characterization and sequence confirmation of unnatural amino acid containing peptide libraries using electrospray ionization mass spectrometry.New dsDNA binding unnatural oligopeptides with pyrimidine selectivity.Evidence for the isomerization and decarboxylation in the photoconversion of the red fluorescent protein DsRed.MccE provides resistance to protein synthesis inhibitor microcin C by acetylating the processed form of the antibiotic.Synthesis and antibacterial evaluation of a novel series of 2-(1,2-dihydro-3-oxo-3H-pyrazol-2-yl)benzothiazoles.A synthetic substrate of DNA polymerase deviating from the bases, sugar, and leaving group of canonical deoxynucleoside triphosphates.Modification of the universally unmodified uridine-33 in a mitochondria-imported edited tRNA and the role of the anticodon arm structure on editing efficiency.Synthesis of a 2,4,6-trisubstituted 5-cyano-pyrimidine library and evaluation of its immunosuppressive activity in a Mixed Lymphocyte Reaction assay.A PKS/NRPS/FAS hybrid gene cluster from Serratia plymuthica RVH1 encoding the biosynthesis of three broad spectrum, zeamine-related antibiotics.An acyclic 5-nitroindazole nucleoside analogue as ambiguous nucleosideN-alkylated aminoacyl sulfamoyladenosines as potential inhibitors of aminoacylation reactions and microcin C analogues containing D-amino acids.Synthesis and structure-activity relationship studies of 2-(1,3,4-oxadiazole-2(3H)-thione)-3-amino-5-arylthieno[2,3-b]pyridines as inhibitors of DRAK2.Imidazopyridine- and purine-thioacetamide derivatives: potent inhibitors of nucleotide pyrophosphatase/phosphodiesterase 1 (NPP1).Hybridization specificity, enzymatic activity and biological (Ha-ras) activity of oligonucleotides containing 2,4-dideoxy-beta-D-erythro-hexopyranosyl nucleosidesMolecular plasticity regulates oligomerization and cytotoxicity of the multipeptide-length amyloid-β peptide poolIdentification of a peptide inhibitor against glycosomal phosphoglycerate kinase of Trypanosoma brucei by a synthetic peptide library approach.Potential for Biocontrol of Hairy Root Disease by a Paenibacillus Clade.Synthesis and cleavage experiments of oligonucleotide conjugates with a diimidazole-derived catalytic center.Synthesis and stability of oligonucleotides containing acyclic achiral nucleoside analogues with two base moieties.Synthesis and base pairing properties of 1',5'-anhydro-L-hexitol nucleic acids (L-HNA).The RNA Modification Database: 1999 update.Isothiazolo[4,3-b]pyridines as inhibitors of cyclin G associated kinase : synthesis, structure-activity relationship studies and antiviral activity.Improved hybridisation potential of oligonucleotides comprising O-methylated anhydrohexitol nucleoside congenersPretargeting of necrotic tumors with biotinylated hypericin using 123I-labeled avidin: evaluation of a two-step strategy.Chemical incorporation of 1-methyladenosine into oligonucleotides.A standardized and biocompatible preparation of aggregate-free amyloid beta peptide for biophysical and biological studies of Alzheimer's disease.Synthesis and hybridization properties of inverse oligonucleotides.Biological effects of hexitol and altritol-modified siRNAs targeting B-Raf.Characterization of insulin-degrading enzyme-mediated cleavage of Aβ in distinct aggregation states.Aminopurine and aminoquinazoline scaffolds for development of potential dengue virus inhibitors.
P50
Q24298670-1615B54F-8F3E-4469-9B71-E0E76FB35D0AQ24793179-67F82343-05F0-48E6-852A-E4EBDDD4D5D9Q27468622-016A9B59-45FA-4824-85E3-FFA064CAE4F6Q27472778-46BE6403-AD30-4560-AB6F-FF5AD77A665FQ27642599-17A39A97-7737-49FB-962A-478F2FCC2758Q28298150-389064AA-5C73-416D-B1C1-2872F9CF63C9Q28477190-B5A90BF4-D521-4C07-BD57-AC6E5D6C0AA8Q28488234-46C59D35-9A90-4712-B30A-18056CC4397FQ30654112-D0AAA023-11AB-4D4B-B539-BCEADC3E1B16Q30831634-E4870F32-934A-49A8-9393-4B97269100F5Q30833404-23424328-F71C-43B9-AEE1-1D376C47EB54Q30845504-85683BA5-CDFD-49B9-A2A7-9E7FA6B2FC61Q33217581-54554BF9-EB9E-48C0-BBF9-7F80D5B9AE04Q33800031-4479362F-7400-483B-8C9C-5EE6E9B51201Q33825490-BD4475F9-D5FA-4D5C-9DA4-50244D6B294DQ34334792-4BE54A2B-974C-4ACB-81C0-75DDCD3BC581Q34364494-61E400B7-0D75-487D-99CF-26599EF6BB17Q34561537-9CD2B2EC-579C-4974-B14F-7F0A06C67078Q34562684-9787E91A-154D-46CC-A26C-747CA8921468Q34778518-20E38AB2-A391-466C-BB39-BE53C3BFE6CCQ35041214-FA20FD0A-8C95-4FD0-8A95-40C08C75B12FQ35229525-77133631-2075-405B-BB11-4E66B76AE44EQ35395384-06304F8A-3CD9-4646-8030-AC392BFC87B9Q35859342-6D4FD9F6-AF63-449A-A103-4C02C5A9B3C8Q36347659-49AE3509-6C23-4BED-83A8-20B2EAF9CD93Q36686791-ABE5987C-78B5-4C40-939A-701F554465EBQ37714475-993DF373-6D81-4441-B940-040BE781A24BQ38291008-317DF666-C012-4143-89F9-757B0BA7AE72Q38346341-A212D728-315C-4570-9CC6-BEE269FB8000Q38350655-1FAEA15C-8519-445F-A582-98AA6523B56BQ38548527-C6292784-0D55-4752-B8B8-979FDC41A9E8Q38597477-675E2CA0-4A44-4994-86EE-7F8BD8B1049CQ39229082-21E8AFCA-F100-45EB-A75B-B2D1EBDB571AQ39424696-6CCD5130-D308-4190-A72F-32DAF5FE3BDEQ39535280-81E6F728-68D3-4979-9DA3-CB249291D6FAQ39544119-9267E3A0-1968-4A09-8607-5C9422CB1069Q39720707-419775AE-AD93-4E38-A633-16C82325EF6FQ39859749-8EE37AAF-FC93-4247-85CE-2BF4E283E4C3Q39927939-F40CFD7F-5BCA-4B38-8582-F9B0904957A6Q40084845-B343E5B8-629C-4372-8AEE-F6747AFCBB4A
P50
description
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Jef Rozenski
@ast
Jef Rozenski
@en
Jef Rozenski
@es
Jef Rozenski
@nl
type
label
Jef Rozenski
@ast
Jef Rozenski
@en
Jef Rozenski
@es
Jef Rozenski
@nl
prefLabel
Jef Rozenski
@ast
Jef Rozenski
@en
Jef Rozenski
@es
Jef Rozenski
@nl
P106
P1153
7006175622
P21
P2456
P31
P496
0000-0001-9624-5536